• Structural Insights into ω-Agatoxin IVA Sensitivity in Cav2.

  2026-07-29

  This study reveals the molecular determinants underlying the variable sensitivity of P- and Q-type Cav2.1 channels to ω-agatoxin IVA. High-resolution cryo-EM structures clarify how specific extracellular loop configurations and alternative splicing define toxin binding, providing a blueprint for targeted modulation of synaptic transmission and neuroprotection strategies.

• Amiloride (MK-870): Optimizing Sodium Channel Research Workf

  2026-07-29

  Amiloride (MK-870) stands out as a dual-action epithelial sodium channel and uPAR inhibitor, empowering researchers to dissect ion transport and endocytosis pathways. This guide translates recent mechanistic insights into actionable, workflow-driven strategies for advanced sodium channel research and cellular endocytosis modulation.

• Syringin Enhances Sunitinib Efficacy in RCC via EGFR/PI3K/Ak

  2026-07-28

  This study presents Syringin, a natural compound, as a novel adjunct in renal cell carcinoma (RCC) therapy by promoting apoptosis and overcoming resistance to Sunitinib. Through targeting the EGFR/PI3K/Akt pathway, Syringin enhances Sunitinib sensitivity and efficacy in RCC models, offering a new avenue for combination strategies against treatment-resistant tumors.

• Glioma Organoids with Native Microenvironment Enable Persona

  2026-07-28

  This study presents a novel methodology for generating glioma organoids that retain the complex microenvironment and cellular interactions of the original tumor. By preserving both genetic/epigenetic fidelity and immune cell composition, the model improves the accuracy of drug screening and therapeutic evaluations in glioma research.

• Diminazene Aceturate in Advanced Mitochondrial and Parasitic

  2026-07-27

  This article provides scenario-driven insights into the application of Diminazene Aceturate (SKU B1729) for cell viability, mitochondrial biogenesis, and trypanosome parasite assays. Addressing real-world laboratory challenges, we discuss protocol optimization, data interpretation, and product reliability, with actionable guidance for biomedical researchers seeking reproducible results using Diminazene Aceturate.

• 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture:

  2026-07-27

  This scenario-driven guide explores how the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture (SKU K1041) addresses persistent challenges in molecular biology assays—offering researchers reproducible outcomes and workflow efficiency. Drawing on published literature and real-world use cases, we examine optimized protocols, troubleshooting strategies, and the practical value of this DNA synthesis reagent for cell viability, proliferation, and nucleic acid delivery studies.

• Caspase-3 Colorimetric Assay Kit: Practical Use and Protocol

  2026-07-26

  The Caspase-3 Colorimetric Assay Kit enables sensitive measurement of DEVD-dependent caspase-3 activity in biological samples, supporting research in apoptosis and neurodegenerative diseases. It is best suited for labs seeking robust, quantitative apoptosis assays, but is not intended for mechanistic studies beyond caspase-3 or for unsupported sample types.

• Strategic Use of Prostaglandin E2 in Translational Inflammat

  2026-07-25

  This article explores the mechanistic underpinnings and translational strategies for leveraging Prostaglandin E2 (PGE2) in inflammation research and regenerative medicine. Integrating recent findings on dual-network hydrogel microspheres for intervertebral disc degeneration, we provide actionable protocol parameters, highlight APExBIO's high-purity PGE2, and discuss clinical and experimental horizons. The discussion is differentiated by bridging advanced delivery technologies with PGE2-mediated immune modulation, offering strategic guidance for translational researchers beyond standard reagent overviews.

• CXCR4-Targeted Theranostic Imaging in Lymphoma: Advances and

  2026-07-24

  This review details how CXCR4-targeted imaging ligands advance lymphoma diagnosis and precision therapy by integrating molecular imaging with targeted interventions. The paper highlights key innovations in imaging agents, therapeutic strategies, and discusses the challenges and future directions for CXCR4-based theranostics.

• Dorsomorphin (Compound C): Unraveling AMPK-BMP Crosstalk in

  2026-07-24

  Discover how Dorsomorphin (Compound C) advances our understanding of AMPK and BMP signaling in choroid plexus barrier integrity and CNS function. This article offers a unique integration of pathway inhibition, macrophage polarization, and translational assay strategies.

• LNP-Delivered NGFR100W mRNA Alleviates Paclitaxel-Induced Ne

  2026-07-23

  This study demonstrates that lipid nanoparticle (LNP) delivery of chemically modified NGFR100W mRNA can effectively promote nerve regeneration and reduce pain in mouse models of paclitaxel-induced peripheral neuropathy. The work introduces a novel, 'painless' mRNA-based approach with significant implications for addressing chemotherapy-related nerve damage.

• Translational Power of EZ Cap Cy5 Firefly Luciferase mRNA

  2026-07-23

  This thought-leadership article explores how the mechanistic features of EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) empower translational researchers to design more insightful and clinically relevant gene delivery and expression studies. By bridging the latest protein corona research with advanced mRNA reporter technology, it offers strategic guidance for optimizing experimental workflows and overcoming the biological barriers that often confound interpretation and translation from bench to bedside.

• 10 mM dNTP Mixture: Precision for Next-Gen DNA Synthesis

  2026-07-22

  Explore the scientific nuances and advanced applications of the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) mixture. This in-depth analysis highlights its unique role as a DNA synthesis reagent and integrates new insights into nucleic acid delivery efficiency.

• ACE2 Activation by Diminazene Aceturate Mitigates Sepsis Car

  2026-07-22

  The referenced study demonstrates that pharmacological activation of ACE2 with Diminazene Aceturate (DIZE) protects against sepsis-induced cardiomyopathy in mice by promoting MasR-Sirt1-mediated mitochondrial biogenesis. These findings clarify a mechanistic link between ACE2 signaling and cardiac protection during sepsis, suggesting new research directions in mitochondrial dysfunction.

• Intestinal TM6SF2 Deficiency Drives Steatohepatitis via LPA

  2026-07-21

  The referenced Nature Metabolism study uncovers how intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by preserving gut barrier integrity and regulating host–microbe interactions. Mechanistically, TM6SF2 deficiency in the gut promotes lysophosphatidic acid (LPA) signaling, linking intestinal lipid handling with hepatic inflammation and establishing new therapeutic entry points for MASH.

16813 records 1/1121 page Next 12345 下5页 Last page